PackTalk is a blog for the Healthcare Packaging Industry

Clinical Trials in Europe Show Promise for Treatment of COVID-19


Published on April 17, 2020

Roche Phase III Covid-19 clinical trial is under way, as United Kingdom Prime Minister Boris Johnson continues his recovery from the novel coronavirus.

As the UK responds to high numbers and their own PM’s brush with death from Covid-19, it is clear no greater need exists than to see approval of life-saving treatments available to the worldwide market. Roche continues to be a major player as the pharmaceutical industry works with global regulatory leaders in the fight against the pandemic.

In March, Pharma Times reported that Roche was approved (with French partner Sanofi, Eusa Pharma and US-based Regeneron) to undertake a Phase III clinical trial (COVACTA). Enrollment of 330 patients from across the world began in early April, with six patients enrolled to date from Spain and the US. Eligible patients must be hospitalized with “severe” Covid-19 pneumonia to be considered for the FDA-backed trial.

Actemra/RoActemra has previously been claimed as part of China’s Covid-19 treatment plan, published by the NHC on March 3, 2020. Existing independent studies for the drug’s use with Covid-19 patients offer limited published findings, such as a three-patient report of major improvement from a Naples, Italy hospital that was then tried at other Italian hospitals. This will be the first well-controlled, global study to clinically examine safety and efficacy. The trial paves the way to confirm or disprove Actemra/RoActemra as a viable treatment for patients suffering serious cases of Covid-19.

Read more here:

 


Comments (0)

Related Articles

Packaging Insights from a Cardiovascular Simulation Center

September 24, 2022

Surgical simulation centers serve as a critical tool for healthcare professionals, offering a means for education, training, and practice for a variety of surgical scenarios in a realistic operating room environment. But these centers can also function as an...

Learn More

Something Wicked This Way Comes to Packaging

September 24, 2022

Unlike the 1962 Ray Bradbury novel, however, Wicked Stability (WS) has nothing to do with creepy traveling carnivals. News of this ambitious and ground-breaking Kilmer Innovations in Packaging (KiiP) project is traveling fast, and its implications are timely,...

Learn More

Perspiration to Inspiration in Wearable Devices

September 24, 2022

There has been plenty of talk about Wearable Medical Devices (WMD) in recent years. Wearable Medical Devices are one of the ultimate healthcare advancements for patients. A wearable can provide reassurance when monitoring a serious health condition, making...

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.